Shanghai OPM Bioengineering Co., Ltd announced a private placement for the gross proceeds of CNY 321,430,000 on September 23, 2022. The transaction includes participation from Shanghai OPM Biosciences Co., Ltd. Out of the total amount received, CNY 30,000,000 will form part of registered capital and rest will be received as capital reserve. The transaction has been approved in the 11th Meeting of the Companyâs 1st Directorate and the 7th Meeting of the 1st Supervisory Board.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
37.71 CNY | +6.65% | +5.96% | -31.65% |
05-09 | OPM Biosciences' Shareholder to Cut Stake | MT |
04-29 | Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.65% | 593M | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |
- Stock Market
- Equities
- 688293 Stock
- News Shanghai OPM Biosciences Co., Ltd.
- Shanghai OPM Bioengineering Co., Ltd. announced that it expects to receive CNY 321.43 million in funding from Shanghai OPM Biosciences Co., Ltd.